title: Effects of in-vitro exposure to HCG on subsequent HCG-responsiveness of human granulosa cells obtained following treatment with GnRH analogue and gonadotrophins: an in-vitro model for luteal phase support.
abstract: The pregnancy rate in patients undergoing assisted conception treatment following pituitary desensitization with GnRH analogue and ovarian stimulation with gonadotrophins has been reported to be higher when ovarian function is supported in the luteal phase by exogenous human chorionic gonadotrophin (HCG). In the present study, we have examined the effects of culturing monolayers of granulosa cells, collected from such patients at oocyte retrieval, for various time intervals in the presence or absence of HCG on their subsequent ability to secrete progesterone (P4) either spontaneously or in response to further challenge with HCG. When cultured in the absence of HCG, granulosa cells demonstrated a rapid decline in both the spontaneous P4 secretion rate and the ability to secrete P4 in response to HCG. Maintenance in the presence of HCG inhibited the rapid decline in ability to secrete P4 spontaneously and also significantly enhanced the ability to respond to subsequent HCG stimulation. These results suggest that HCG support in the luteal phase in GnRH analogue-treated patients may have a cellular basis for its action both in maintenance of P4 secretion and also in rendering the corpus luteum more sensitive to rescue by conceptus-derived HCG.
authors.affiliation: Unit of Reproductive Medicine, Ninewells Hospital and Medical School, Dundee, UK.
authors.forename: D H
authors.initials: DH
authors.lastname: Edgar
authors.forename: K M
authors.initials: KM
authors.lastname: Whalley
authors.forename: J A
authors.initials: JA
authors.lastname: Gemmell
authors.forename: G B
authors.initials: GB
authors.lastname: James
authors.forename: J A
authors.initials: JA
authors.lastname: Mills
mesh_terms: D002064:Buserelin / Q000627:therapeutic use*; D002478:Cells, Cultured; D006063:Chorionic Gonadotropin / Q000494:pharmacology* / Q000502:physiology; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods; D015181:Gamete Intrafallopian Transfer / Q000379:methods; D006107:Granulosa Cells / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D008183:Luteal Phase / Q000187:drug effects*; D008596:Menotropins / Q000494:pharmacology*; D011374:Progesterone / Q000378:metabolism
chemical_list: D006063:Chorionic Gonadotropin; D011374:Progesterone; D008596:Menotropins; D002064:Buserelin